| Risk of hepatitis B virus reactivation in patients treated with immunotherapy for anti-cancer treatment S Yoo, D Lee, JH Shim, KM Kim, YS Lim, HC Lee, C Yoo, BY Ryoo, J Choi Clinical Gastroenterology and Hepatology 20 (4), 898-907, 2022 | 46 | 2022 |
| Serum sorbitol dehydrogenase as a novel prognostic factor for hepatocellular carcinoma after surgical resection D Jeon, WM Choi, JS Kim, Y Jung, SY Lee, HR Seo, KM Kim Cancers 13 (23), 6143, 2021 | 8 | 2021 |
| Argininosuccinate synthase 1 suppresses tumor progression through activation of PERK/eIF2α/ATF4/CHOP axis in hepatocellular carcinoma S Kim, M Lee, Y Song, SY Lee, I Choi, IS Park, J Kim, J Kim, K Kim, ... Journal of Experimental & Clinical Cancer Research 40, 1-18, 2021 | 28 | 2021 |
| Kinetics of the neutrophil‐lymphocyte ratio during PD‐1 inhibition as a prognostic factor in advanced hepatocellular carcinoma WM Choi, JY Kim, J Choi, D Lee, JH Shim, YS Lim, HC Lee, C Yoo, ... Liver International 41 (9), 2189-2199, 2021 | 35 | 2021 |
| Clinical outcomes with multikinase inhibitors after progression on first-line atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma: a multinational … C Yoo, JH Kim, MH Ryu, SR Park, D Lee, KM Kim, JH Shim, YS Lim, ... Liver Cancer 10 (2), 107-114, 2021 | 83 | 2021 |
| Stereotactic body radiation therapy for small (≤ 5 cm) hepatocellular carcinoma not amenable to curative treatment: results of a single-arm, phase II clinical trial SM Yoon, SY Kim, YS Lim, KM Kim, JH Shim, D Lee, J An, J Jung, JH Kim, ... Clinical and molecular hepatology 26 (4), 506, 2020 | 60 | 2020 |
| Development of machine learning-based clinical decision support system for hepatocellular carcinoma GH Choi, J Yun, J Choi, D Lee, JH Shim, HC Lee, YH Chung, YS Lee, ... Scientific reports 10 (1), 14855, 2020 | 35 | 2020 |
| Lymphocyte to monocyte ratio-based nomogram for predicting outcomes of hepatocellular carcinoma treated with sorafenib Y Ha, MA Mohamed Ali, MM Petersen, WS Harmsen, TM Therneau, ... Hepatology international 14, 776-787, 2020 | 17 | 2020 |
| Real-world efficacy and safety of lenvatinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis J Cheon, HJ Chon, Y Bang, NH Park, JW Shin, KM Kim, HC Lee, J Lee, ... Liver Cancer 9 (5), 613-624, 2020 | 49 | 2020 |
| Effectiveness and safety of nivolumab in Child–Pugh b patients with hepatocellular carcinoma: a real-world cohort study WM Choi, D Lee, JH Shim, KM Kim, YS Lim, HC Lee, C Yoo, SR Park, ... Cancers 12 (7), 1968, 2020 | 50 | 2020 |
| Regorafenib versus nivolumab after sorafenib failure: Real‐world data in patients with hepatocellular carcinoma WM Choi, J Choi, D Lee, JH Shim, YS Lim, HC Lee, YH Chung, YS Lee, ... Hepatology communications 4 (7), 1073-1086, 2020 | 35 | 2020 |
| Inhibitors of Na+/K+ ATPase exhibit antitumor effects on multicellular tumor spheroids of hepatocellular carcinoma Y Song, SY Lee, S Kim, I Choi, SH Kim, D Shum, J Heo, AR Kim, KM Kim, ... Scientific reports 10 (1), 5318, 2020 | 29 | 2020 |
| Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma J Choi, D Lee, JH Shim, KM Kim, YS Lim, YS Lee, HC Lee PLoS One 15 (3), e0229696, 2020 | 21 | 2020 |
| Ablation of intrahepatic cholangiocarcinoma J Sweeney, N Parikh, G El-Haddad, B Kis Seminars in Interventional Radiology 36 (04), 298-302, 2019 | 24 | 2019 |
| Long‐term clinical outcomes in patients with autoimmune hepatitis according to treatment response in Asian country J Choi, GH Choi, D Lee, JH Shim, YS Lim, HC Lee, YH Chung, YS Lee, ... Liver international 39 (5), 985-994, 2019 | 31 | 2019 |
| LI-RADS classification and prognosis of primary liver cancers at gadoxetic acid–enhanced MRI SH Choi, SS Lee, SH Park, KM Kim, E Yu, Y Park, YM Shin, MG Lee Radiology 290 (2), 388-397, 2019 | 144 | 2019 |
| Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up JH Lee, JH Lee, YS Lim, JE Yeon, TJ Song, SJ Yu, GY Gwak, KM Kim, ... Cancer Immunology, Immunotherapy 68 (1), 23-32, 2019 | 79 | 2019 |
| Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently F Bazerbachi, S Haffar, Z Wang, J Cabezas, MT Arias-loste, J Crespo, ... | | 2019 |
| Range of normal liver stiffness and predictors of suspected advanced fibrosis in apparently healthy individuals: a pooled analysis of 16,082 participants F Bazerbachi, S Haffar, Z Wang, JC González, MT Arias-Loste, J Crespo, ... Clinical Gastroenterology and Hepatology, 2019 | 4 | 2019 |
| Range of normal liver stiffness and factors associated with increased stiffness measurements in apparently healthy individuals F Bazerbachi, S Haffar, Z Wang, J Cabezas, MT Arias-Loste, J Crespo, ... Clinical Gastroenterology and Hepatology 17 (1), 54-64. e1, 2019 | 79 | 2019 |
